Sunshine Biopharma Stock Price, News & Analysis
Company Description
Sunshine Biopharma (NASDAQ: SBFMW) is a publicly traded company in the Pharmaceutical Preparations sector.
SBFMW stock has declined 72.6% over the past year. Shares last traded at $0.0725.
On a trailing twelve-month basis, Sunshine Biopharma reported revenue of $36.3M with net income of -$6.0M. The company operates at a net profit margin of -16.5%.
This page provides a comprehensive overview of SBFMW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sunshine Biopharma (SBFMW) stock last traded at $0.0725, down 23.86% from the previous close. Over the past 12 months, the stock has lost 72.6%.
SBFMW Rankings
Latest News
Sunshine Biopharma has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, private placement, covid-19, buybacks. View all SBFMW news →
SEC Filings
Sunshine Biopharma has filed 10 recent SEC filings, including 4 Form 8-K, 4 Form SCHEDULE 13G, 2 Form 10-Q. The most recent filing was submitted on May 29, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SBFMW SEC filings →
Financial Highlights
Sunshine Biopharma generated $36.3M in revenue over the trailing twelve months, retaining a 33.8% gross margin, operating income reached -$6.2M (-17.2% operating margin), and net income was -$6.0M, reflecting a -16.5% net profit margin. The company generated -$5.3M in operating cash flow. With a current ratio of 4.17, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Sunshine Biopharma (SBFMW) currently stands at 5.6 thousand shares, representing 0.2% of the float. Over the past 12 months, short interest has decreased by 20.9%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Sunshine Biopharma (SBFMW) currently stands at 1000.0 days, up 592.2% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 20518.4% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
SBFMW Company Profile & Sector Positioning
Sunshine Biopharma (SBFMW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.
Investors comparing SBFMW often look at related companies in the same sector, including Biofrontera (BFRIW), Clever Leaves Holdings Inc (CLVRW), Sunshine Biopharma Inc (SBFM), Inmed Pharmaceuticals Inc (INM), and Aytu Biopharma Inc (AYTU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SBFMW's relative position within its industry.